The persistent challenges of bacterial infections in the transplant recipient

Transplant Infectious Disease

Volumn 8, Issue 3, 2006, Pages 125-127

  Marty, F M ^a   Rubin, R H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PYELONEPHRITIS; BACTERIAL INFECTION; EDITORIAL; GRAFT INFECTION; GRAFT RECIPIENT; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; TUBERCULOSIS;

ANTI-INFECTIVE AGENTS; HUMANS; IMMUNOSUPPRESSION; INFECTION; TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 33746896573     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2006.00168.x     Document Type: Editorial

References (17)

1. RUBIN RH, IKONEN T, GUMMERT JF, MORRIS RE. The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies. Transpl Infect Dis 1999: 1: 29-39.
2. RUBIN RH. Infection in the organ transplant recipient. In: RUBIN RH, YOUNG LS, eds. Clinical Approach to Infection in the Compromised Host (4th edn). New York: Kluwer Academic/Plenum, 2002: 573-679.
3. KAMATH NS, JOHN GT, NEELAKANTATAN N, KORUBAKARAN MG, JACOB CK. Acute graft pyelonephritis following renal transplantation. Transpl Infect Dis 2006: 8: 140-147.
4. CHEN C-H, LIAN J-D, CHENG C-H, WU M-J, LEE W-C, SHU K-H. Mycobacterium tuberculosis infection following renal transplantation in Taiwan. Transpl Infect Dis 2006: 8: 148-156.
5. FOX BC, SOLLINGER HW, BELZER FO, MAKI DG. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim- sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990: 89: 255-274.
6. TOLKOFF-RUBIN NE, COSIMI AB, RUSSELL PS, RUBIN RH. A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis 1982: 4: 614-618.
7. TOLKOFF-RUBIN NE, RUBIN RH. Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic. Infect Dis Clin North Am 1997: 11: 707-717.
8. RUBIN RH. The compromised host as sentinel chicken. N Engl J Med 1987: 317: 1151-1153.
9. FISCHER SA, GRAHAM MB, KUEHNERT MJ, et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006: 354: 2235-2249.
10. SRINIVASAN A, BURTON EC, KUEHNERT MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005: 352: 1103-1111.
11. MCALLISTER WA, THOMPSON PJ, AL-HABET SM, ROGERS HJ. Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 1983: 286: 923-925.
12. EDWARDS OM, COURTENAY-EVANS RJ, GALLEY JM, HUNTER J, TAIT AD. Changes in cortisol metabolism following rifampicin therapy. Lancet 1974: 2: 548-551.
13. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000: 49: 1-125, CE1-7.
14. JOHN GT, THOMAS PP, THOMAS M, JEYASEELAN L, JACOB CK, SHASTRY JC. A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 1994: 57: 1683-1684.
15. AGARWAL SK, GUPTA S, DASH SC, BHOWMIK D, TIWARI SC. Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient. Int Urol Nephrol 2004: 36: 425-431.
16. VIKRANT S, AGARWAL SK, GUPTA S, et al. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy. Transpl Infect Dis 2005: 7: 99-108.
17. PAI M, RILEY LW, COLFORD JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004: 4: 761-776.